AptaBio Therapeutics Inc Balance Sheet Statement

293780 KRW54700 -2,200.0 -3.9%

05/03/21

Highly Speculative, Mid Cap, Momentum Trap

Market Cap £383.5m

Enterprise Value £357.3m

Revenue £356k

Quality

Value

Momentum

StockRank™

To unlock AptaBio Therapeutics Inc's balance sheet statement please upgrade your membership.

	2017	2018	2019
Period End:	2017-12-31	2018-12-31	2019-12-31
Period Length:	0	0	0
Currency:	KRW	KRW	KRW

Cash
Cash & Equivalents
Short Term Investments
Cash and Short Term Investments
Accounts Receivable - Trade, Net
Total Receivables, Net
Prepaid Expenses
Other Current Assets, Total
Total Current Assets

Property/Plant/Equipment, Total - Gross
Accumulated Depreciation, Total
Property/Plant/Equipment, Total - Net
Intangibles, Net
Long Term Investments
Other Long Term Assets, Total
Total Assets

Payable/Accrued
Accrued Expenses
Notes Payable/Short Term Debt
Current Port. of LT Debt/Capital Leases
Other Current Liabilities, Total
Total Current Liabilities

Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Other Liabilities, Total
Pension Deficit
Total Liabilities

Common Stock
Additional Paid-In Capital
Retained Earnings (Accumulated Deficit)
Total Equity

Total Liabilities & Shareholders’ Equity
Total Common Shares Outstanding

Unlock Stockopedia Premium for free!

See what it can do for your stockpicking and portfolio at no expense.